Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Left Ventricular Mass Regression in Type 2 Diabetes with Ischemic Heart Disease
NCT01947790Phase 4Completed
- Start
- Sep 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pioglitazone in type 2 diabetes mellitus (T2DM) (2 arms). Primary endpoint: Changes of Left Ventricular Mass (LVM) at 9 months. Started Sep 2013; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01947790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01947790.